EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma

Kenji Mizumura, Yasuhiro Gon, Norihiro Harada, Shiho Yamada, Asami Fukuda, Ryosuke Ozoe, Shuichiro Maruoka, Sumiko Abe, Kazuhisa Takahashi, Akihiko Tanaka, Hironori Sagara, Taisuke Akamatsu und 14 weitere

Allergology International · 2025-01 · 74 (1) · 144-155

DOI: 10.1016/j.alit.2024.08.005 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Allergology International, 2025-01. Verfasst von Kenji Mizumura und 25 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan. Electronic address: mizumura.ke…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Asthma, Biomarkers, Eosinophils. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedAsthmaBiomarkersEosinophilsAdultAgedFemaleHumansMaleMiddle AgedAnti-Asthmatic AgentsLeukocyte CountNitric OxideProspective StudiesRespiratory Function TestsSeverity of Illness IndexSputumTreatment Outcome

Stichwörter der Autor:innen

AsthmaDupilumabEosinophilFractional exhaled nitric oxideSputum

Substanzen

Anti-Asthmatic AgentsAntibodies, Monoclonal, HumanizedBiomarkersdupilumabNitric Oxide

Autor:innen und Institutionen

  • Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan. Electronic address: mizumura.kenji@nihon-u.ac.jp.
  • Division of Respiratory Medicine, Department of Internal Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Department of Respiratory Medicine, Faculty of Medicine and Graduate School of Medicine, Juntendo University, Tokyo, Japan.
  • Division of Respiratory Medicine and Allergology, Department of Medicine, School of Medicine, Showa University, Tokyo, Japan.
  • Department of Respiratory Medicine, Shizuoka General Hospital, Shizuoka, Japan.
  • Division of Pulmonary Medicine, Department of Medicine, Keio University School of Medicine, Tokyo, Japan.

Zitieren

APA

Mizumura, K., Gon, Y., Harada, N., Yamada, S., Fukuda, A., Ozoe, R., Maruoka, S., Abe, S., Takahashi, K., Tanaka, A., Sagara, H., Akamatsu, T., Shirai, T., Masaki, K., Fukunaga, K., Kobayashi, K., Nagase, H., Miyahara, N., Kanehiro, A., …, & Tagaya, E. (2025). Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma. Allergology International, 74(1), 144-155. https://doi.org/10.1016/j.alit.2024.08.005

Vancouver

Mizumura K, Gon Y, Harada N, Yamada S, Fukuda A, Ozoe R, et al. Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma. Allergology International. 2025;74(1):144-155. doi:10.1016/j.alit.2024.08.005

BibTeX
@article{Mizumura2025,
  author = {Mizumura, Kenji and Gon, Yasuhiro and Harada, Norihiro and Yamada, Shiho and Fukuda, Asami and Ozoe, Ryosuke and Maruoka, Shuichiro and Abe, Sumiko and Takahashi, Kazuhisa and Tanaka, Akihiko and Sagara, Hironori and Akamatsu, Taisuke and Shirai, Toshihiro and Masaki, Katsunori and Fukunaga, Koichi and Kobayashi, Konomi and Nagase, Hiroyuki and Miyahara, Nobuaki and Kanehiro, Arihiko and Kitamura, Noboru and Sugihara, Naruhiko and Kumasawa, Fumio and Terada-Hirashima, Junko and Hojo, Masayuki and Chibana, Kazuyuki and Tagaya, Etsuko},
  title = {Predicting dupilumab effectiveness with Type-2 biomarkers: A real-world study of severe asthma},
  journal = {Allergology International},
  year = {2025},
  volume = {74},
  number = {1},
  pages = {144--155},
  doi = {10.1016/j.alit.2024.08.005}
}
Kostenlos starten →